RXRX

Recursion Pharmaceuticals, Inc.

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$3.11

Market Cap

$1.39B

Beta

1.01

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+27.48%

EPS Growth (YoY)+10.84%

Revenue CAGR 3Y+23.40%

P/E Ratio0.0

PEG Ratio—

FCF Yield-27.20%

Debt / Equity0.07

Interest Coverage-493.6x

No credit card required

Already have an account? Sign in to view the full analysis for RXRX.